Answers are grounded in this paper and cite their sources.
Nationwide case-control study finds anti-TNF therapy increases risk of autoimmune diseases in IBD, suggesting need for careful monitoring.
Anti-TNF therapy for IBD is associated with an increased risk of developing new-onset autoimmune diseases, especially psoriasis and ILD. Careful monitoring is warranted, particularly in patients receiving prolonged or combined immunosuppressive therapies.
No takes yet. Share an insight, caveat, or question.
Oh et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: